Cytolytic molecules in rejection.

Curr Opin Organ Transplant

Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Published: February 2009

Purpose Of Review: Acute and chronic rejection are major problems in clinical transplantation. Rejection is largely mediated by natural killer (NK) and T cells that use cytolytic molecules, including perforin, granzymes, granulysin, and Fas ligand, to eliminate the allograft. The purpose of this review is to inform the reader of recent advances in our understanding of the roles of cytolytic molecules in rejection and their potential as biomarkers of rejection.

Recent Findings: Although it is well accepted that T cells are the major effector cells in acute rejection, there is an increasing recognition that cells of the innate immune system, and in particular NK cells, also play a major role in allograft rejection.

Summary: Both NK cells and cytotoxic T cells contribute to acute rejection. The major molecules involved include perforin, granzymes, granulysin, and Fas ligand. Molecular profiles that include these and other molecules may allow better management of organ allograft recipients.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOT.0b013e32831c8462DOI Listing

Publication Analysis

Top Keywords

cytolytic molecules
12
molecules rejection
8
purpose review
8
rejection major
8
perforin granzymes
8
granzymes granulysin
8
granulysin fas
8
fas ligand
8
acute rejection
8
cells
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!